Showing results (1-10 of 92) with videos related to

Sort By:
Pageof 10
Klinische Monatsblatter Fur Augenheilkunde|May 16, 2017
[Anti(lymph)angiogenic Strategies to Improve Corneal Graft Survival]Felix Bock, Claus Cursiefen
Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics|July 9, 2015
Thrombospondin-1 as a Regulator of Corneal Inflammation and Lymphangiogenesis: Effects on Dry Eye Disease and Corneal Graft ImmunologyLaura Schöllhorn, Felix Bock, Claus Cursiefen
Journal of Clinical Medicine|May 2, 2020
Immunomodulatory Strategies Targeting Dendritic Cells to Improve Corneal Graft SurvivalAlfrun Schönberg, Matthias Hamdorf, Felix Bock
Current Opinion in Allergy and Clinical Immunology|September 7, 2012
Corneal angiogenesis and lymphangiogenesisBirgit Regenfuss, Felix Bock, Claus Cursiefen
Plos One|October 27, 2011
Intravital two-photon microscopy of immune cell dynamics in corneal lymphatic vesselsPhilipp Steven, Felix Bock, Gereon Hüttmann, et al.
Lymphatic Research and Biology|December 20, 2008
Corneal (lymph)angiogenesis--from bedside to bench and back: a tribute to Judah FolkmanBirgit Regenfuss, Felix Bock, Anand Parthasarathy, et al.
Translational Vision Science & Technology|May 9, 2022
Posttransplant VEGFR1R2 Trap Eye Drops Inhibit Corneal (Lymph)angiogenesis and Improve Corneal Allograft Survival in Eyes at High Risk of RejectionWei Zhang, Alfrun Schönberg, Felix Bock, et al.
Graefe'S Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Fur Klinische Und Experimentelle Ophthalmologie|October 16, 2007
Bevacizumab (Avastin) eye drops inhibit corneal neovascularizationFelix Bock, Yanyan König, Friedrich Kruse, et al.
Experimental Eye Research|September 28, 2025
Promotion of vessel regression by local VEGF-A blockade improves the survival rate of corneal transplantsZhe Chen, Wei Zhang, Mert Mestanoglu, et al.
Pageof 10